
Join to View Full Profile
2800 Main StreetBridgeport, CT 06606
Phone+1 203-576-6000
Dr. Blondin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a Neuro-Oncologist at Smilow Cancer Hospital in New Haven, CT. I am a lifelong Connecticut resident, having been born, raised and educated entirely in Connecticut. After graduating from Litchfield High School as valedictorian, I graduated with Honors in Chemistry from Wesleyan University. I then obtained my medical degree from the University of Connecticut School of Medicine, and completed internship and residency training at Yale-New Haven Hospital, serving as Chief Resident in Neurology during my final year. I then completed a clinical fellowship in Neuro-Oncology at Yale-New Haven Hospital. I have an interest in all aspects of neurology, as well as specialized expertise in the treatment brain tumors such as glioblastomas, oligodendrogliomas, astrocytomas, meningiomas, as well as the treatment of metastatic brain tumors and neurological symptoms related to cancer. I am interested in clinical research focusing on new therapies, and improving patient quality of life.
Education & Training
Yale-New Haven Medical CenterFellowship, Neuro-Oncology, 2012 - 2013
Yale-New Haven Medical CenterChief Residency, Neurology, 2011 - 2012
Yale-New Haven Medical CenterResidency, Neurology, 2009 - 2011
Yale-New Haven Medical CenterInternship, Internal Medicine, 2008 - 2009
Uconn School Of MedicineClass of 2008, MD
Certifications & Licensure
CT State Medical License 2012 - 2027
American Board of Psychiatry and Neurology Neurology- United Council of Neurological SubspecialtiesNeuro-Oncology
Awards, Honors, & Recognition
- Humanitarian Award CT Brain Tumor Alliance, 2018
- CMS Meaningful Use Stage 1 Certification VertexDR, Meridian Medical Management, 2014, 2016
- Gold Humanism Honor Society Yale School of Medicine, 2013
Publications & Presentations
PubMed
- Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.Patrick Y Wen, Donald A Berry, Meredith B Buxton, Howard Colman, John de Groot
Journal of Clinical Oncology. 2026-04-14 - Representation of neuro-oncology in American neurology departments: An analysis of Grand Rounds and perspectives from faculty and residents.Elizabeth C Neil, Aubree Bruhnding, Zubair A Ahmed, Priya U Kumthekar, Nicholas A Blondin
Neuro-Oncology Practice. 2025-12-01 - CLO25-069: Single Dose Nivolumab and Ipilimumab Treatment Causing Complete and Durable Response in Extensive Stage Small Cell Lung Cancer Complicated By Severe Sensory...Aaron Charles Lobo, Nur Rahman, Nicholas Blondin, Neal Fischbach
Journal of the National Comprehensive Cancer Network. 2025-03-28
Journal Articles
- Anaplastic Gliomas: Radiation, Chemotherapy or Both?Blondin NA, Becker KP, Hematol Oncol Clin North Am, 8/1/2012
- Prevalence, awareness, treatment and control of hypertension in a rural Nicaraguan sampleBlondin NA, Lewis J, J Hum Hypertens
Professional Memberships
- Member
- Society for Neuro-OncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









